medigraphic.com

2025, Number 4

<< Back Next >>

Enf Infec Microbiol 2025; 45 (4)

Clinical-epidemiological characteristics of 52 patients with phoniatric disorders secondary to Kawasaki disease

Andrade-Montes WE, Briceño-Barrios ÉM, González-Mata AJ

Language: Spanish
References: 24
Page: 181-185
PDF size: 229.37 Kb.


ABSTRACT

Kawasaki disease is an acute vasculitis that affects small and medium caliber vessels. It is the first cause of acquired heart disease in children, it can be accompanied by extracardiac conditions. With the objective of determining the clinic-epidemiological characteristics of pediatric patients with phoniatric alterations secondary to Kawasaki disease.
Material and methods. Honiatric consultation. Deconcentrated Service Dr. Agustín Zubillaga Pediatric University Hospital, during the period April to July 2023. A prospective cross-sectional descriptive study was carried out, selected through intentional non-probabilistic sampling. The sample consisted of 52 patients who met the inclusion criteria. The data collection instrument was carried out through the questionnaire, consisting of three sections; validated by expert. Data were analyzed using SPSS 22 and results were presented in tables.
Results. The highest percentage was found in: preschoolers (54%), male sex (58%), urban origin (69%) and Graffar scale IV (65%). The incomplete clinical presentation of Kawasaki disease predominated in 63%. Auditory symptoms were observed in 56% and voice alteration (dysphonia) in 17%. Auditory signs and symptoms were predominantly otalgia in 23%. The peaee and at show that normal hearing predominated in 71% and 29% presented some degree of hearing loss. In patients with predominantly bilateral superficial hearing loss in 58%. Neurosensory taking first place in 75%. Therefore, it is crucial to make an early diagnosis, timely treatment, and avoid cardiac and extracardiac complications of this disease, in order to protect this vulnerable population.


REFERENCES

  1. Aggarwal, V., Etinger V. y Orjuela, A.F., “Sensorineuralhearing loss in Kawasaki disease”, Ann Pediatr Cardiol, 2016, 9 (1) :87-89. doi: 10.4103/09742069.171396. pmid:27011703; pmcid: pmc4782479. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4782479/.

  2. Gil Veloz, M., Flores Ruiz, E.M., Beirana Palencia, L.,Miranda Novales, M.G., Huerta García, G.C. y SolórzanoSantos, F. “Enfermedad de Kawasaki: comportamientoclínico y complicaciones cardiovasculares en niñosatendidos en un hospital de tercer nivel”, Arch CardiolMex, 2009, 79 (1): 11-17.

  3. American Heart Association. Disponible en: https://www.medigraphic.com/pdfs/juarez/ju-2018/ju183f.pdf.

  4. Baleato Gómez, B., González Ávila, C., Souto Cainzos,B., Iglesias González, B., González Menchén, C. y RamosAmador, J.T., “Revisión clínica y diagnóstica de la enfermedad de Kawasaki: estudio descriptivo, retrospectivo yanalítico”, Rev Pediatr Aten Primaria, 2018, 20 (77).

  5. Arias Cabello, B., Fernández Álvarez, H. y Ordaz Favila, J.C. “Manifestaciones oculares en enfermedad deKawasaki. Experiencia en el Instituto Nacional de Pediatría”, Rev Mex Oftalmol, 2016, 90 (1): 3-8. Disponible en:http://www.svpediatria.org/repositorio/articulos-de-interes/55/Anzoategui_kawasaki_ocular.pdf.

  6. Canale, A., Lacilla, M., Cavalot, A.L. y Albera, R., “Auditory steady-state responses and clinical applications”,Eur Arch Otorhinolaryngol, 2006, 263: 499-503.

  7. Chen, S., Dong, Y., Kiuchi, M.G., Wang, J., Li, R., Ling,Z., et al., “Coronary Artery Complication in Kawasakidisease and the importance of early intervention: asystematic review and meta-analysis”, jama Pediatrics,2016, 170: 1156-1163.

  8. Asociación Española de Pediatría, “Consenso nacionalsobre diagnóstico, tratamiento y seguimiento cardiológico de la enfermedad de Kawasaki”, An Pediatr (Barcelona), 2019, 90: 134510. doi: 1016/j.anpedi.2018.11.00.Disponible en: https://www.analesdepediatria.org/es-consenso-nacional-sobre-diagnostico-tratamiento-articulo-S1695403318301516.

  9. Franco, V., Carnevale, M., “Perfil clínico y epidemiológicode la enfermedad de Kawasaki: Hospital Pediátrico Dr.Agustín Zubillaga”, Boletín Médico de Postgrado, 2020,37 (1): 27-33. Disponible en: https://revistas.uclave.org/index.php/bmp/article/view/2824.

  10. Smith, K. y Yunker W.K., “Kawasaki disease is associatedwith sensorineural hearing loss: a systematic review”,International Journal of Pediatric Otorhinolaryngology,2014, 78: 1216-1220.

  11. Rao, R.M., Rajils Raveendran, E.R., Nidha, K., Namitha,P., Prabhu, P. y Nisha, K.V., “Audio-vestibular manifestations in Kawasaki disease (kd): a rare atypical casepresentation”, The Egyptian Journal of Otolaryngology,2022, 38: 101. Disponible en: https://ejo.springeropen.com/articles/10.1186/s43163-022-00279-x.

  12. González-Mata, A., Ulloa-Gutiérrez, R., Brea, J., Soza, G.y Tremoulet, A.H., “Origin and importance of the LatinAmerican Kawasaki disease Network (Rekamlatina)”,Rev Chil Infectol (internet), 2014, 6 de junio.

  13. González Mata, A., Maitin, G., Carnevale, T. y Santana,R., “Enfermedad de Kawasaki: presentación inusualcon sólo fiebre”, 2019, Barquisimeto, Venezuela. Reporte breve. Disponible en: https://www.medigraphic.com/pdfs/micro/ei-2019/ei193b.pdf.

  14. González Mata, A.J., Maitin, G.M.J., Carnevale, M.,Santana Hospital rmi y Briceño, E. “Enfermedad deKawasaki, afectación extracardiaca, Hospital Universitario Pediátrico Agustín Zubillaga (hupaz), Servicio deInfectología, Servicio de Foniatría, 2021, Barquisimeto,Venezuela.

  15. McCrindle, B.W., Rowley, A.H., Newburger, J.W., Burns,J.C., Bolger, A.F. et al., “Diagnosis, treatment, and longterm management of Kawasaki disease: a scientificstatement for health professionals from the AmericanHeart Association”, Circulation, 2017, 135 (17): e927.Epub 29 de marzo de 2017.

  16. Newburger, J.W. et al., “Kawasaki disease”, en F.D. Burget al. (eds.), Current pediatric therapy, 18ª, ed., Filadelfia,Saunders, 2006, pp. 497-503.

  17. Organización Mundial de la Salud (oms), “Enfermedadde Kawasaki: relación, síntomas. Enfermedad deKawasaki niños, covid-19. Disponible en: https://www.infosalus.com/salud-investigacion/noticia-oms-estudia-relacion-sintomas-enfermedad-kawasaki-ninos-covid-19-20200515183915.html.

  18. Quimís, Y., Delgado, K. y Pardo, M., “Revisión sistemática de la enfermedad de Kawasaki: epidemiología, diagnóstico y tratamiento en América Latina”, Dom Cien,2021, 7 (6): 1564-1584.

  19. Medina Carías, R., Mejía Machado, M.P., Araujo, L. yPrado López L.M., “Enfermedad de Kawasaki. Revisiónbibilografica”, Acta Pediátrica Hondureña, 2018, 8 (2).

  20. Gámez-González, L.B., Ulloa-Gutiérrez, R., Murata, C.,Yamazaki-Nakashimada, M.A., Kim, E., Estripeaut, D.,Del Águila, O., Garrido-García, L.M., Gómez, V., Faugier-Fuentes, E., Miño, G., Beltrán, S., Cofré, F., Chacón-Cruz, E., Saltigeral-Simental, P., Martínez-Medina,L. y Tremoulet, A.H., “Kawasaki disease RekamlatinaNetwork; Astigarraga N. Kawasaki disease presentingwith hoarseness: a multinational study of the Rekamlatina Network”, Pediatr Int, 2021, 63 (6): 643-648. doi:10.1111/ped.14521. Epub: 27 de mayo de 2021. pmid:33099854. Disponible en: https://onlinelibrary.wiley.com/doi/epdf/10.1111/ped.14521.

  21. Saulsbury FT (2010). Kawasaki syndrome. In GL Mandell et al., Mandell, Douglas, and Bennett’s Principlesand Practice of Infectious Diseases, 7th ed., vol. 2, pp.3663-3666. Philadelphia: Churchill Livingstone Elsevier.https://www.aeped.es/sites/default/files/documentos/3-kawasaki.pdf.

  22. Sundel, R., Gitelman, M.K. y Kaplan, S., “Kawasaki disease: initial treatment and prognosis”, 2 de mayo de 2012.

  23. Sundel, R.P., Newburger, J.W., Mcgill, T. et al, “Sensori-neural hearing loss associated with Kawasaki disease”, J Pediatr,1990, 117: 371-377.

  24. Yamazaki- Nakashimada, M.A., “El enigma de la enfermedad de Kawasaki”, Rev Latin de Infect Pediat, 2019,32 (2). Disponible en: https://www.medigraphic.com/pdfs/infectologia/lip-2019/lip192a.pdf.




2020     |     www.medigraphic.com